KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Shares Issued (2016 - 2025)

Merck (MRK) has disclosed Shares Issued for 17 consecutive years, with $47.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued rose 291.67% to $47.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $92.0 million, a 48.02% decrease, with the full-year FY2025 number at $92.0 million, down 48.02% from a year prior.
  • Shares Issued was $47.0 million for Q4 2025 at Merck, up from $14.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $265.0 million in Q4 2022 to a low of $5.0 million in Q3 2024.
  • A 5-year average of $49.0 million and a median of $18.0 million in 2021 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: soared 538.1% in 2021, then plummeted 97.74% in 2023.
  • Merck's Shares Issued stood at $134.0 million in 2021, then skyrocketed by 97.76% to $265.0 million in 2022, then tumbled by 97.74% to $6.0 million in 2023, then surged by 100.0% to $12.0 million in 2024, then skyrocketed by 291.67% to $47.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRK's Shares Issued are $47.0 million (Q4 2025), $14.0 million (Q3 2025), and $12.0 million (Q2 2025).